Individuals with EBV-positive infectious mononucleosis show a higher incidence of MS compared with matched controls in a long-term cohort study.

Laboratory-confirmed Epstein-Barr virus-positive infectious mononucleosis (EBV-mono) was linked to a more than threefold higher risk for multiple sclerosis (MS) than not having EBV-mono, a new ...

Add Yahoo as a preferred source to see more of our stories on Google. New human antibodies block Epstein-Barr virus infection in mice, offering hope for transplant patients at high risk. (CREDIT: ...

The Epstein-Barr virus seems to affect gene expression and cell signalling in a way that causes the autoimmune condition ...

Scientists have taken a major step toward stopping Epstein-Barr virus (EBV), an extremely common infection linked to cancer ...

Infectious mononucleosis, the illness most teenagers know simply as “mono,” may carry consequences that extend far beyond weeks of fatigue and missed school. A growing body of research now ties the ...

A common virus that causes mononucleosis – the 'kissing disease' – could more than triple the risk of developing multiple sclerosis, a devastating autoimmune disease that ravages the central nervous ...

Having the disease infectious mononucleosis, often called mono, caused by the Epstein-Barr virus is associated with an increased risk of developing multiple sclerosis (MS), according to a study ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb 25 (Reuters) - Researchers may be closer to developing a vaccine that ...

SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...

Multiple sclerosis, often called MS, is a long-term disease that affects the brain and spinal cord. It happens when the body’s immune system mistakenly attacks its own nerve cells. In particular, it ...

Feb 25 (Reuters) - (Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here.) ...